Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans

University of Hohenheim

Status: Completed

Conditions: Cardiovascular Risk

Treatments: Dietary Supplement: Energy Drink, Taurine, Caffeine

Study type: Interventional

Funder types: Other

Identifiers

NCT01421979

ED2011

Details and patient eligibility

About

The aim of this study is to examine the safety and the effects of EDs at high doses, either alone or in combination with other risk factors such as alcohol intake, physical exercise and sleep deprivation, on cardiovascular markers and subjective health.

Enrollment: 38 patients

Sex: All

Ages: 18 to 25 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• written informed consent
• healthy (no acute or chronic desease)
• BMI 20,0 - 25,9 kg/m2
• moderate and non-regular consumption of alcohol, EDs and coffee

Exclusion criteria

• pregnancy
• regular medication (oral contraceptives permitted)
• hypertension and other deseases of the cardiovascular system
• liver-deseases
• psychiatric deseases
• epilepsy
• other relevant deseases
• (former) alcoholics
• non-compliance to the study-protocol
• simultaneous participation in another clinical trial
• retraction of the written informed consent

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Quadruple Blind

---

38 participants in 2 patient groups

exposure under sleep deprivation

Experimental group

Description:

Examination of the effects of EDs in combination with alcohol consumption and sleep deprivation.

Treatment:

Dietary Supplement: Energy Drink, Taurine, Caffeine

Exercise after consumption

Experimental group

Description:

Examination of the effects of EDs in combination with alcohol consumption and exercise.

Treatment:

Dietary Supplement: Energy Drink, Taurine, Caffeine